-
Eli Lilly, Novo Nordisk, Sanofi accused of conspiring to push up insulin prices
Time of Update: 2022-08-15
CompileDravenThe state of Arkansas has taken Eli Lilly, Novo Nordisk, Sanofi and three major Pharmacy Benefits Managers (PBMs) to court, accusing them of conspiring to raise the price of insulin and other diabetes-related drugs .
-
Top 100 domestic pharmaceutical companies' product R&D rankings announced: Junshi, Hengrui, CanSino...
Time of Update: 2022-08-15
In recent years, driven by a series of drug administration reforms and the national science and technology innovation strategy, the research and development of innovative drugs has been in full swing
-
Orphan drugs will account for 1/3 of the global drug pipeline value, how will domestic research and development go?
Time of Update: 2022-08-15
Favorable policies work together to promote the domestic orphan drug market Therefore, in recent years, China has successively introduced various types of supporting policies related to rare disease diagnosis, drug development and registration, medical security, taxation, etc.
-
In the first half of the year, a large number of multinational pharmaceutical companies such as Pfizer, Merck, and BMS maintained growth in performance
Time of Update: 2022-08-15
769 billion, a year-on-year increase of 70% According to Pfizer’s performance report for the first half of 2022, the company achieved total revenue of US$53.
494 billion, a year-on-year increase of 41% after deducting exchange rate effects Merck's 2022 first half financial report shows that the company achieved a total revenue of US$30.
-
New standards are coming, and the outlook for the standard system of pharmaceutical packaging materials in the 2025 edition of the Chinese Pharmacopoeia
Time of Update: 2022-08-15
Looking forward to the general technical requirements for the standard system of pharmaceutical packaging materials that may be included in the 2025 edition of the Chinese Pharmacopoeia, the list is as follows: 3 summary The Chinese Pharmacopoeia standards have received extensive attention from all parties involved in the research and development, production, use, review and supervision of pharmaceutical packaging materials and drugs .
-
In order to improve the efficiency of research and development, there is constant news of cooperation between pharmaceutical companies and technology companies!
Time of Update: 2022-08-15
Recently, Yunnan Baiyao announced that it has signed a comprehensive cooperation agreement with Huawei to carry out extensive exchanges and cooperation in the field of artificial intelligence drug research and development, including large and small molecule design, related diseases, database development, etc.
-
Layoffs, delisting, bankruptcy!
Time of Update: 2022-08-15
The overseas capital market has responded quickly, and some Biotech companies have come to an end: On April 8, 2022, Kaleido Biosciences, an American microbial pharmaceutical company, filed an application announcing its intention to cease operations, lay off remaining employees and delist from the Nasdaq exchange .
-
Under the centralized procurement, the consistency evaluation of generic drugs is actively promoted
Time of Update: 2022-08-15
Lisheng Pharmaceutical announced at noon on May 5 that recently, the company received the "Approval Notice for Supplementary Drug Application" issued by the State Food and Drug Administration for Donepezil Hydrochloride Tablets 5mg, which passed the quality and efficacy consistency evaluation of generic drugs .
-
CDE: "Guidelines for Blinding of Drug Clinical Trials" Released for Comments
Time of Update: 2022-08-15
Scan the QR code to view the original text Source: National Bureau Review Center Editor: wangxinlai2004 On July 25, 2022, the Evaluation Center of the State Administration issued the "Guiding Principles for Blinding of Drug Clinical Trials (Draft for Comment)", and the time limit for soliciting comments is 1 month from the date of release .
-
The clinical trial of Zhongsheng Pharmaceutical's oral new crown drug RAY1216 was accepted today's daily limit
Time of Update: 2022-08-15
On the evening of May 11, Zhongsheng Pharmaceutical issued an announcement stating that the clinical trial registration application for the innovative drug RAY1216 tablets of oral anti-new coronavirus 3CL protease inhibitor, Zhongsheng Ruichuang, a holding subsidiary, was accepted by the National Medical Products Administration (NMPA).
-
In 2021, there are no Chinese pharmaceutical companies in the top ten global generic drug companies. Where is the spring of domestic generic drugs?
Time of Update: 2022-08-15
Teva -- sales have fallen for 5 years in a row Teva Pharmaceuticals is a global pharmaceutical company headquartered in Israel and one of the largest generic drug manufacturers in the world.
-
MNC semi-annual report: Novartis, Johnson & Johnson, Abbott, Roche "lead the way"!
Time of Update: 2022-08-15
Profits of Novartis and Johnson & Johnson declined; Bojian’s net profit doubled in the second quarter, but the stock market fell; Abbott’s profit increased, but was still negatively affected by the recall and discontinuation of infant formula in February; Roche’s innovative drug performance far exceeded expectations, making up for the disadvantage of “old drugs” .
-
Have those pharmaceutical companies that cross the 100 billion medical beauty market become "beautiful"?
Time of Update: 2022-08-15
Among them, in the international market, the financial report shows that in 2021, Sinclair, a subsidiary of Huadong Medicine’s international medical beauty business, will achieve a consolidated operating income of about 665 million yuan, a year-on-year increase of 108.
-
Full of goodies!
Time of Update: 2022-08-15
From researcher Zhang Lan, director of the Water Quality and Health Monitoring Office of the China Institute of Disease Control and Environment, Liu Li, ICP-MS technical support for PerkinElmer's inorganic production line, and Ma Jiping, director of the School Analysis and Testing Center, Deputy Dean of the School of Environmental and Municipal Engineering, Qingdao University of Technology Participated in this online forum and made relevant interpretations on the content of the new GB 5749 standard .
-
The continuous promotion of direct settlement of medical insurance across provinces and different places greatly reduces the pressure on patients to advance funds
Time of Update: 2022-08-15
1893 million person-times According to the data provided by the National Medical Insurance Bureau, at present, the cross-provincial direct settlement of hospitalization expenses has reached 57,300 designated medical institutions, which basically cover all the first to third-level designated hospitals.
-
Announcement on the draft standard of magnesium trisilicate, disodium edetate, aluminum hydroxide and powdered cellulose pharmaceutical excipients
Time of Update: 2022-08-15
pdf Our committee plans to revise the standards for pharmaceutical excipients of magnesium trisilicate, disodium edetate, aluminum hydroxide and powdered cellulose.
pdf Our committee plans to revise the standards for pharmaceutical excipients of magnesium trisilicate, disodium edetate, aluminum hydroxide and powdered cellulose.
-
Enthusiasm for the research and development of oncology drugs is high. This pharmaceutical company has 9 new class 1 tumor drugs approved for clinical use during the year.
Time of Update: 2022-08-15
[Pharmaceutical Network Industry News] According to CDE's public information, Hengrui Medicine's HRS-4642 injection has recently been approved for clinical use in KRAS G12D-mutated advanced solid tumors .
-
In 2021, the total number of new drug clinical trial registrations in China exceeded 3,000 for the first time, and the research and development of PD-1/PD-L1 is particularly outstanding!
Time of Update: 2022-08-15
The "Report" shows that according to the classification of chemical drugs, biological products and traditional Chinese medicines, from the data analysis of the past three years, the proportion of new drug clinical trials of chemical drugs and biological products is relatively high, with an annual average of 54.
-
More than 10 pharmaceutical companies announced their "transcripts" in the first half of the year, and many net profits doubled
Time of Update: 2022-08-15
. In the first half of 2022, the company achieved revenue of 642 million yuan, a year-on-year increase of 41.
97%, and profitability accelerated In the first half of 2022, the company achieved revenue of 642 million yuan, a year-on-year increase of 41.
-
The use of essential medicines has been upgraded!
Time of Update: 2022-08-15
What has attracted much attention from the industry is that the new version of the "Operation Manual" further clarifies that the number of varieties of essential drugs purchased and the proportion of their use are included in the assessment points of secondary public hospitals .
